All-in-one instrument for molecular diagnostics
The geneLEAD VIII, manufactured by PSS and distributed by Diagenode Diagnostics in Europe, is a new all-in-one automated molecular diagnostics platform designed for carrying out small series of tests (1,000 to 4,000 tests/year), from nucleic acid extraction to patient result in 1,5 hour. This instrument can independently perform up to 8 different real-time PCR tests, without or with extraction validated on whole blood, serum, plasma, urine, CSF, swab, sputum and stool. Combining expertise in the development of molecular diagnostic assays acquired over the last 14 years, Diagenode Diagnostics presents here the first in a range of multiplex tests for the geneLEAD VIII, focused on respiratory and gastrointestinal infections, including Influenza A & B virus, together with respiratory syncytial virus (RSV), Mycobacterium tuberculosis complex, Legionella pneumophila & spp, Adenovirus (mid-2019), Bordetella pertussis & parapertussis (late 2019), Norovirus I / II & Rotavirus (late 2019) and Mycoplasma pneumoniae (2020). The geneLEAD VIII is also compatible with Laboratory Developed Tests (LDT) based on real-time PCR and other detection chemistries. The geneLEAD VIII represents a unique CE-IVD solution which is ready for accreditation, easy-to-use and allowing workflow optimization with the middle-to-high-throughput automated systems in molecular diagnostics laboratories.